Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Investigational Lubricating Eye Drop in a Novelia® bottle
Investigational Lubricating Eye in a Novelia bottle · 1 trial · 1 indication
Subjective ocular comfort was assessed at baseline, and at 30-day follow-up using a Visual Analogue Scale (VAS) with continuous scale from 0 (extremely uncomfortable) to 100 (extremely comfortable). The change from baseline ocular comfort score was calculated as 30-day follow-up score minus baseline score. Change from baseline VAS scores range from -100 to 100, where higher change from baseline comfort scores indicates better performance. The average change from baseline comfort score for each Arm was reported.
| Arm | Type | Description |
|---|---|---|
| Investigational product | EXPERIMENTAL | Eligible subjects will be randomly assigned the investigational product to be used in both eyes for the duration of the study. |
| Control product | ACTIVE_COMPARATOR | Eligible subjects will be randomly assigned the control product to be used in both eyes for the duration of the study |
| Name | Type | Description |
|---|---|---|
| Investigational Lubricating Eye Drop in a Novelia® bottle | DRUG | Investigational Product |
| Blink® Tears eye Drops | DRUG | Control Product |
Inclusion Criteria: Potential subjects must satisfy all of the following criteria to be enrolled in the study: 1. Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. 2. Appear able and willing to adhere to the instructions set forth in this c...
It is an investigational lubricating eye drop supplied in a Novelia bottle, a multidose preservative-free eye dropper. Johnson & Johnson is developing it for dry eye, and it is also known as the Investigational Lubricating Eye Drop in a Novelia bottle. It is a small molecule product in Phase 2 development.
It is being studied for dry eye. The Phase 2 trial enrolled non-contact lens wearing patients with dry eye, and it evaluated the multidose preservative-free lubricating eye drops contained in a Novelia eye dropper. The product has not been approved and remains investigational.
Johnson & Johnson, which trades under the ticker JNJ, is the developer of the Investigational Lubricating Eye in a Novelia bottle. The product is an ophthalmology asset studied for dry eye and is also referred to as the Investigational Lubricating Eye Drop in a Novelia bottle.
It is in Phase 2 development. One Phase 2 trial of the Investigational Lubricating Eye in a Novelia bottle has been completed, and no trials are currently active. The product is investigational and has not been approved for any use.
The Investigational Lubricating Eye in a Novelia bottle was studied in NCT05661851, titled Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia Eye Dropper in Non-Contact Lens Wearing Patients. That Phase 2 trial is completed, enrolled 121 participants, was randomized and active-controlled, and took place in the United States.
Yes. The Investigational Lubricating Eye in a Novelia bottle is also known as the Investigational Lubricating Eye Drop in a Novelia bottle. Both names refer to the same Johnson & Johnson ophthalmology asset, a small molecule lubricating eye drop in a Novelia bottle being studied for dry eye.